Management of Minimal Supraspinatus Tendinopathy and Minimal Subacromial-Subdeltoid Bursitis
Begin with a supervised exercise program combined with NSAIDs as first-line treatment for minimal supraspinatus tendinopathy and minimal subacromial-subdeltoid bursitis. 1
Initial Conservative Management
The American Academy of Orthopaedic Surgeons provides moderate-grade evidence that patients with rotator cuff-related symptoms without full-thickness tears should be initially treated nonsurgically using exercise and/or NSAIDs 1. This applies directly to your minimal tendinopathy and bursitis scenario.
Exercise Therapy Specifics
- Supervised exercise programs show superior outcomes compared to home-based programs alone, particularly when combined with manual therapy 2
- Level II studies demonstrate significant improvements in pain (VAS scores), function (Constant-Murley scores), and range of motion after 8-12 weeks of structured exercise 1
- The exercise program should include:
- Range of motion exercises
- Progressive strengthening exercises
- Stretching protocols
- Dynamic stability training 3
The addition of manual therapy (joint and soft tissue mobilization) to supervised exercise may enhance functional outcomes, though all three approaches (supervised exercise alone, supervised exercise with manual therapy, and home exercise) show effectiveness 2.
Medication Considerations
NSAIDs can be used concurrently with exercise therapy, though the guideline evidence is inconclusive regarding their independent efficacy 1. Given the minimal nature of your pathology, NSAIDs serve primarily as adjunctive pain control to facilitate exercise participation.
Injection Therapy: When and What
Corticosteroid injections have conflicting evidence - five level II studies show variable results for pain and function at 2-6 weeks, making this an inconclusive recommendation 1. However, given your minimal pathology, reserve injections for:
- Failure of 6-8 weeks of exercise therapy
- Pain limiting participation in rehabilitation
- Need for rapid symptom control
Emerging Injection Options
Recent high-quality evidence suggests ultrasound-guided dextrose prolotherapy (20% dextrose, 10mL) combined with therapeutic exercise produces superior outcomes compared to saline injection plus exercise for subacromial-subdeltoid bursitis 4. This 2026 pilot RCT showed:
- Significant improvements in SPADI total scores (group × time P=.004)
- Better pain reduction (P=.001)
- Enhanced range of motion in abduction and rotation
- Well-tolerated with only transient post-injection soreness
If considering injection therapy, ultrasound guidance is essential to ensure accurate bursal placement and optimize outcomes 5.
Treatment Algorithm
Weeks 0-12: Supervised exercise program ± NSAIDs
- Assess response at 4 weeks and 12 weeks
- Greatest improvements typically seen by 12 weeks 2
If inadequate response at 6-8 weeks: Consider adding:
Continue exercise therapy throughout - injection alone is insufficient 4, 5
Critical Caveats
Avoid these common pitfalls:
- Do not rely on passive modalities alone (ice, heat, ultrasound, TENS, iontophoresis) - evidence is insufficient to recommend for or against these 1
- Do not perform corticosteroid injections without concurrent rehabilitation programming
- Do not proceed to surgery for minimal pathology - this is a non-operative condition 6
Preserve the subacromial bursa whenever possible - it contains intrinsic trophic and pluripotent factors critical for rotator cuff healing 7. This is particularly relevant if pathology progresses and surgical intervention becomes necessary in the future.
Monitoring Response
Expect significant improvements in:
- Pain at rest and with activity (VAS reduction)
- Shoulder range of motion (flexion, abduction, rotation)
- Functional scores (SPADI, DASH)
- Muscle strength with manual testing 2, 3
If no improvement after 3-6 months of comprehensive conservative management, reassess with MRI to evaluate for progression to full-thickness tear or other pathology requiring surgical consideration 6.